NEW YORK (GenomeWeb News) — Roche Diagnostics today said it plans to acquire 454 Life Sciences from CuraGen for $155 million in cash and stock.
Under the deal, Roche will put up $140 million in cash and as much as $14.9 million in outstanding stock options to acquire the subsidiary, which is now seeing early sales of its next-generation sequencers. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.

Sponsored by
Thermo Fisher Scientific

In this webinar, the first in the “New Frontiers in Liquid Biopsy Research” series, Bea Bellosillo, head of pathology at the Hospital del Mar, will discuss her experience evaluating an early-access lung cancer panel that detects copy number variants and fusions.